Insights On Outsourced Drug Development

  1. Elevating Purity: Racemizing Pharmaceutical Products In Flow Microreactors 6/18/2025

    Discover how our process development team resolved a racemization challenge by delivering a biologically active racemic mixture while maintaining compound purity.

  2. Innovative Strategies For Residual DNA And Viral Titre Quantitation 5/22/2025

    Discover how digital PCR improves the accuracy of residual host cell DNA and viral titre quantification in biotherapeutic manufacturing to enhance product quality, safety, and regulatory compliance.

  3. 384-Well Microplate Time Resolved Fluorescence (TRF) Immunoassay 9/18/2024

    Examine how innovative sandwich ELISAs in a 384-well format can be utilized with a sensitive reader for high-throughput screening to quantify Human IgG and IFN gamma.

  4. Quantification Of Semaglutide With A Reliable Analytical Method 7/17/2025

    Explore a validated LC-MS/MS method for precise Semaglutide quantification in plasma, which features enhanced sensitivity, peak definition, and reproducibility using innovative technologies.

  5. Softgel Formulation: Addressing Stability, Shelf-Life, And Bioavailability 5/16/2024

    A CDMO that has expertise and resources in softgel formulation can help companies address stability issues, improve drug bioavailability, or ensure compliance with regulations.

  6. A Translational Mouse Model For Non-Genetic Heterotopic Ossification 3/28/2025

    Reproducing the thermal lesion/tenotomy-induced mouse model can help overcome the challenge of unpredictable heterotopic ossification localization and enable the development of targeted interventions.

  7. Formulation Of Crystalline Nanoparticles Enabling Superior Drug Load 8/13/2024

    Explore how bioavailability of poorly soluble APIs can be improved and patient compliance enhanced by reducing the size or number of tablets that a patient must take to achieve the required dose.

  8. MAPK Signaling Pathway 4/7/2025

    Mitogen-activated protein kinase cascades regulate key cellular processes like proliferation, differentiation, and apoptosis. Explore how these pathways maintain cellular homeostasis and contribute to disease development.

  9. A New Framework For Identifying Nitrosamine Risks And Derisking Products 6/18/2024

    Examine a new methodology that holds significant promise for identifying APIs at risk for NDSRI formation, enabling manufacturers to prioritize risk mitigation strategies and ensure compliance.

  10. A Solvent-Free, Fusion-Based ASD Manufacturing Process 3/5/2024

    Explore a solvent-free alternative for the production of amorphous solid dispersions (ASDs) that not only improves manufacturability but also reduces the carbon footprint of ASD manufacturing.